Importantly, a recent report indicated that three proteins, Aβ, TREM2 and Clusterin, display an early increase in patients with severe Aβ pathology but no detectable cognitive defects (Nelson et al., 2012) and in patients with mild cognitive impairment, with continuous accumulation in AD. This evidence concerns the gene CLU and Alzheimer disease.